Research Portal

Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma

Research output: Contribution to journal › Letter › peer-review

Standard Standard

Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma. / Jenkinson, Michael; Weber, Damien; Haylock, Brian et al.
In: Journal of Neurology, Neurosurgery and Psychiatry, 17.08.2018.

Research output: Contribution to journal › Letter › peer-review

HarvardHarvard

Jenkinson, M, Weber, D, Haylock, B, Sherratt, F, Young, B, Weller, M, Bulbeck, H, Culeddu, G, Hughes, D, Brain, A, Das, K, Preusser, M, Francis, P & Gamble, C 2018, 'Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma', Journal of Neurology, Neurosurgery and Psychiatry. https://doi.org/10.3171/2018.6.JNS181418

APA

Jenkinson, M., Weber, D., Haylock, B., Sherratt, F., Young, B., Weller, M., Bulbeck, H., Culeddu, G., Hughes, D., Brain, A., Das, K., Preusser, M., Francis, P., & Gamble, C. (2018). Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma. Journal of Neurology, Neurosurgery and Psychiatry. https://doi.org/10.3171/2018.6.JNS181418

CBE

Jenkinson M, Weber D, Haylock B, Sherratt F, Young B, Weller M, Bulbeck H, Culeddu G, Hughes D, Brain A, et al. 2018. Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma. Journal of Neurology, Neurosurgery and Psychiatry. https://doi.org/10.3171/2018.6.JNS181418

MLA

Jenkinson, Michael et al. "Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma". Journal of Neurology, Neurosurgery and Psychiatry. 2018. https://doi.org/10.3171/2018.6.JNS181418

VancouverVancouver

Jenkinson M, Weber D, Haylock B, Sherratt F, Young B, Weller M et al. Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma. Journal of Neurology, Neurosurgery and Psychiatry. 2018 Aug 17. doi: 10.3171/2018.6.JNS181418

Author

Jenkinson, Michael ; Weber, Damien ; Haylock, Brian et al. / Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma. In: Journal of Neurology, Neurosurgery and Psychiatry. 2018.

RIS

TY - JOUR

T1 - Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma

AU - Jenkinson, Michael

AU - Weber, Damien

AU - Haylock, Brian

AU - Sherratt, Frances

AU - Young, Bridget

AU - Weller, Micheal

AU - Bulbeck, Helen

AU - Culeddu, Giovanna

AU - Hughes, Dyfrig

AU - Brain, Alice

AU - Das, Kumar

AU - Preusser, Matthias

AU - Francis, Priya

AU - Gamble, Carrol

PY - 2018/8/17

Y1 - 2018/8/17

U2 - 10.3171/2018.6.JNS181418

DO - 10.3171/2018.6.JNS181418

M3 - Letter

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

ER -